Yasmine Radwan
Overview
Explore the profile of Yasmine Radwan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
37
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mills E, Avila Y, Beasock D, Radwan Y, Suptela S, Marriott I, et al.
Nanomedicine
. 2024 Jun;
60:102762.
PMID: 38866196
Recalcitrant staphylococcal osteomyelitis may be due, in part, to the ability of Staphylococcus aureus to invade bone cells. However, osteoclasts and osteoblasts are now recognized to shape host responses to...
2.
Brumett R, Danai L, Coffman A, Radwan Y, Teter M, Hayth H, et al.
Biochemistry
. 2024 Jan;
63(3):312-325.
PMID: 38271599
We report a thorough investigation of the role of single-stranded thymidine (ssT) linkers in the stability and flexibility of minimal, multistranded DNA nanostructures. We systematically explore the impact of varying...
3.
Suptela A, Radwan Y, Richardson C, Yan S, Afonin K, Marriott I
Inflammation
. 2023 Dec;
47(2):822-836.
PMID: 38148453
Genomic instability is a key driving force for the development and progression of many age-related neurodegenerative diseases and central nervous system (CNS) cancers. Recently, the cytosolic DNA sensor, cyclic GMP-AMP...
4.
Radwan Y, Rebolledo L, Panigaj M, Afonin K
Methods Mol Biol
. 2023 Aug;
2709:309-318.
PMID: 37572291
Nucleic acid nanotechnology utilizes natural and synthetic structural motifs to build versatile nucleic acid nanoparticles (NANPs). These rationally designed assemblies can be further equipped with functional nucleic acids and other...
5.
Radwan Y, Afonin K, Johnson M
Methods Mol Biol
. 2023 Aug;
2709:211-228.
PMID: 37572283
Nucleic acid nanoparticles (NANPs) are extensively investigated as diagnostic and therapeutic tools. These innovative particles can be composed of RNA, DNA, and/or modified nucleic acids. Due to the regulatory role...
6.
Newton H, Radwan Y, Xu J, Clogston J, Dobrovolskaia M, Afonin K
Molecules
. 2023 Jun;
28(11).
PMID: 37298960
Nucleic acid nanoparticles (NANPs) require a carrier to allow for their intracellular delivery to immune cells. Cytokine production, specifically type I and III interferons, allows for reliable monitoring of the...
7.
Radwan Y, Arafa K, Ghoniem M, Al-Farraj E, El-Sherbiny I
Drug Dev Ind Pharm
. 2023 Apr;
49(3):271-280.
PMID: 37067846
Background: Breast cancer conventional therapeutics are effective; however, they encounter some limitations including multidrug resistance, the presence of pharmacological barriers, and non-selectivity which hinder their optimal therapeutic efficacy. Aim: Overcoming...
8.
Klotz K, Radwan Y, Chakrabarti K
Molecules
. 2023 Jan;
28(1).
PMID: 36615420
Nucleic acid nanoparticles (NANPs) are an exciting and innovative technology in the context of both basic and biomedical research. Made of DNA, RNA, or their chemical analogs, NANPs are programmed...
9.
Bila D, Radwan Y, Dobrovolskaia M, Panigaj M, Afonin K
Molecules
. 2021 Jul;
26(14).
PMID: 34299506
The relatively straightforward methods of designing and assembling various functional nucleic acids into nanoparticles offer advantages for applications in diverse diagnostic and therapeutic approaches. However, due to the novelty of...
10.
Abdel-Rahman E, Hosseiny S, Aaliya A, Adel M, Yasseen B, Al-Okda A, et al.
J Adv Res
. 2021 Jul;
31:35-47.
PMID: 34194831
Introduction: Incidents of myocardial infarction and sudden cardiac arrest vary with time of the day, but the mechanism for this effect is not clear. We hypothesized that diurnal changes in...